Affymetrix (AFFX) Misses Q3 EPS by 4c
More News related to AFFX
- Trading Overview for Sequenom Inc. Issued by StockPreacher.com
- Deutsche Bank Upgrades Affymetrix (AFFX) to Hold; Risk/Reward Appears Balanced
- Developing Countries Sign up for Pharmacogenomics for Every Nation Initiative Using the Affymetrix DMET(TM) Plus Panel
- Morning Movers 10/22: HTE, SDXC, SXI, NYT, FFIV, SKX, JCG Higher; TQNT, WSTL, NWK, EPAX, AFFX, NCR Lower
- After-Hours Movers 10/21: SDXC, FFIV, HNI, COHU, GGG, SKX, LHO Higher; AFFX, NVEC, TEX, ADS, EBAY, EQIX Lower
Affymetrix (NASDAQ: AFFX) reports Q3 loss of $0.13, 4 cents below the analyst estimate of ($0.09). Revenue for the quarter was $78.2 million, which compares to the estimate of $80.67 million.
Related Categories
EarningsStocks Mentioned
+0.04Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
